How to Get Haegarda Approved by Blue Cross Blue Shield of North Carolina: Complete Prior Authorization Guide

Quick Answer: Getting Haegarda Covered by BCBS North Carolina

Blue Cross Blue Shield of North Carolina requires prior authorization for Haegarda (C1-esterase inhibitor, SC) as specialty tier medication. Key requirements: confirmed HAE diagnosis (ICD-10 D84.1), lab values showing low C1-INH and C4 levels, documented attack history, and completion of step therapy or medical exemption. Submit through the BCBS NC provider portal with comprehensive clinical documentation. Standard review takes 15 business days; expedited available for urgent cases. If denied, you have 180 days to appeal internally, then 120 days for Smart NC external review.

First step today: Verify your specific BCBS NC plan's formulary tier for Haegarda and download the current prior authorization form.


Table of Contents

What This Guide Covers

This comprehensive guide helps patients with hereditary angioedema (HAE) and their healthcare providers navigate the prior authorization process for Haegarda with Blue Cross Blue Shield of North Carolina. We'll walk through every step from initial documentation to appeals, including North Carolina's unique Smart NC external review process.

Haegarda (subcutaneous C1-esterase inhibitor) is a plasma-derived prophylactic treatment for HAE attacks in patients 6 years and older. As a high-cost specialty biologic, it requires careful documentation and often faces step therapy requirements before approval.

Before You Start: Plan Verification

Confirm Your Plan Type

  • Check if you have a state-regulated plan (most individual and small group plans) or a self-funded employer plan
  • Self-funded plans may not be subject to North Carolina external review rights
  • Call the member services number on your insurance card to verify

Verify Network Status

  • Ensure your prescribing physician is in-network with BCBS NC
  • Confirm your preferred specialty pharmacy is covered
  • Out-of-network providers may require additional authorization steps

Check Formulary Status Haegarda is typically placed on Tier 4 or Tier 5 (highest specialty tier) with significant cost-sharing. Review your plan's current formulary to understand:

  • Your copay or coinsurance amount
  • Whether step therapy applies
  • Quantity limits or site-of-care restrictions

Requirements at a Glance

Requirement What It Means Where to Find It
PA Required Yes, for all BCBS NC plans BCBS NC PA Requirements
Formulary Tier Tier 4-5 (specialty) Your plan's drug list
Step Therapy May require trying alternatives first Plan-specific criteria
Age Requirement ≥6 years (FDA approved) FDA Haegarda Label
Diagnosis Code ICD-10 D84.1 (HAE) Clinical documentation
Lab Requirements Low C1-INH and C4 levels Recent lab results
Training Plan Subcutaneous administration Haegarda Connect Program
Appeal Deadline 180 days (commercial) BCBS NC member materials

Step-by-Step: Fastest Path to Approval

1. Obtain Specialist Consultation

Who: Allergist, immunologist, or hematologist
Timeline: Schedule ASAP if not already established
Why: Specialist prescriptions have higher approval rates

2. Complete Diagnostic Workup

Required Labs:

  • C1-esterase inhibitor (antigenic and functional)
  • C4 complement level (must be below normal)
  • Consider genetic testing if labs are inconclusive

3. Document Attack History

Include:

  • Frequency and severity of HAE attacks
  • Emergency department visits or hospitalizations
  • Impact on quality of life and daily activities

4. Address Step Therapy Requirements

If required, document:

  • Previous HAE medications tried and failed
  • Contraindications to preferred alternatives
  • Adverse reactions to other treatments

5. Complete Training Requirements

Enroll in: Haegarda Connect for patient education
Document: Completion of subcutaneous injection training
Include: Administration plan and site rotation schedule

6. Submit Complete PA Request

Use: Current BCBS NC pharmacy prior authorization form
Submit via: Provider portal or designated fax line
Include: All supporting documentation in single submission

7. Follow Up Proactively

Timeline: Call within 5-7 business days of submission
Track: Reference numbers and case status
Escalate: Request peer-to-peer review if initial denial

Gather Your Documentation

Clinical Documentation Checklist

  • Confirmed HAE diagnosis (ICD-10 D84.1)
  • Laboratory results showing low C1-INH and C4 levels
  • Detailed attack history (frequency, severity, triggers)
  • Prior medication trials and outcomes
  • Contraindications to step therapy alternatives
  • Current medication list and allergies
  • Recent clinic notes from HAE specialist
  • Training completion documentation
  • Dosing plan (typically 60 IU/kg twice weekly)

Required Forms

  • Primary: BCBS NC Pharmacy Prior Authorization Form
  • Supporting: Prescriber attestation letter
  • Patient: Insurance card and identification
Tip: Create a comprehensive "PA packet" with all documents before starting. This prevents delays from missing information requests.

Submit Your Request

Electronic Submission (Preferred)

Portal: BCBS NC Provider Portal
Account: Requires provider registration
Advantage: Faster processing and tracking capabilities

Fax Submission

Use when: Electronic submission unavailable
Include: Cover sheet with patient information
Confirm: Successful transmission with fax receipt

Clean Submission Checklist

  • All form fields completed
  • Legible signatures and dates
  • Supporting documents attached
  • Correct patient and provider information
  • Reference to specific BCBS NC criteria met

Follow-Up and Timelines

Standard Review Timeline

BCBS NC Standard: 15 business days from complete submission
Expedited Review: 72 hours for urgent cases
Incomplete Requests: Additional 15 days after missing information provided

Proactive Follow-Up Strategy

Day 5-7: Call to confirm receipt and completeness
Day 10: Check status and expected decision date
Day 14: If no decision, request escalation to supervisor

Sample Phone Script

"Hello, I'm calling to check on a prior authorization request for Haegarda submitted on [date] for patient [name], member ID [number]. Can you confirm the status and let me know if any additional information is needed?"

If You're Asked for More Information

Common Additional Requests

  • Medical Necessity Letter: Detailed clinical rationale from prescriber
  • Peer Review Literature: Published studies supporting Haegarda use
  • Specialty Guidelines: HAE management recommendations
  • Prior Authorization History: Documentation of previous medication trials

Medical Necessity Letter Components

  1. Patient Background: Age, diagnosis, attack history
  2. Clinical Rationale: Why Haegarda is medically necessary
  3. Alternative Considerations: Why other options aren't suitable
  4. Expected Outcomes: Treatment goals and monitoring plan
  5. Supporting Evidence: Guidelines and literature citations
Counterforce Health helps healthcare providers create comprehensive, evidence-backed prior authorization requests and appeals. Our platform analyzes denial patterns and generates targeted responses that align with specific payer criteria, potentially reducing the time to approval for complex specialty medications like Haegarda.

If Your Request is Denied

Common Denial Reasons and Solutions

Denial Reason Solution Strategy
Step therapy not completed Document contraindications or previous failures
Diagnosis not confirmed Submit additional lab results or genetic testing
Lack of specialist involvement Transfer care to allergist/immunologist
Training not documented Complete Haegarda Connect program
Medical necessity unclear Provide detailed attack history and impact

Internal Appeal Process

Deadline: 180 days from denial date (commercial plans)
Required: Written appeal with supporting evidence
Timeline: BCBS NC has 30 days to respond
Escalation: Request peer-to-peer review with medical director

Peer-to-Peer Review Request

When to Use: After initial denial or during appeal
Participants: Prescribing physician and BCBS NC medical director
Preparation: Review denial reason and prepare clinical arguments
Documentation: Take notes during call and follow up in writing

Smart NC External Review Process

North Carolina offers one of the strongest external review programs in the country through Smart NC, administered by the Department of Insurance.

Eligibility Requirements

  • Must exhaust internal BCBS NC appeals first
  • State-regulated insurance plan (not self-funded employer plans)
  • Denial based on medical necessity or experimental treatment determination
  • Request filed within 120 days of final internal denial

How to Request External Review

Contact: Smart NC at 855-408-1212
Form: External Review Request Form
Support: Smart NC staff provide free assistance with paperwork
Cost: No charge to consumers

External Review Timeline

Standard Review: Decision within 45 days
Expedited Review: Decision within 72 hours for urgent cases
Binding Decision: If overturned, BCBS NC must provide coverage within 3 business days

What to Include

  • Final denial letter from BCBS NC
  • All medical records and supporting documentation
  • Additional literature or guidelines supporting medical necessity
  • Written statement from prescribing physician
From Our Advocates: We've seen numerous HAE medication denials overturned through North Carolina's external review process, particularly when patients provided comprehensive attack histories and documentation of failed alternative therapies. The key is thorough preparation and leveraging Smart NC's free support services.

Renewal and Re-authorization

When to Start Renewal Process

Timeline: Begin 60-90 days before current authorization expires
Calendar Reminder: Set alerts for renewal deadlines
Proactive Approach: Don't wait for pharmacy to notify you

Renewal Documentation

  • Updated attack frequency and severity data
  • Treatment response and benefit documentation
  • Any changes in clinical status
  • Continued medical necessity
  • Updated lab values if requested

Patient Support and Cost Assistance

Manufacturer Support Programs

Haegarda Connect: Patient education and injection training
Website: haegarda.com/support-resources
Services: Nurse support, insurance navigation, copay assistance

Additional Resources

  • National Organization for Rare Disorders (NORD): Financial assistance programs
  • HAE Association: Patient advocacy and support
  • North Carolina Patient Advocate Foundation: Insurance navigation assistance

For patients who need comprehensive support navigating complex insurance approvals, Counterforce Health provides specialized services that help turn denials into approvals through evidence-based appeals and targeted advocacy.

Frequently Asked Questions

How long does BCBS NC prior authorization take for Haegarda?
Standard review is 15 business days from complete submission. Expedited review is available within 72 hours for urgent cases where delay could jeopardize health.

What if Haegarda is not on my BCBS NC formulary?
You can request a formulary exception by demonstrating medical necessity and providing evidence that covered alternatives are inappropriate or ineffective.

Can I request an expedited appeal in North Carolina?
Yes, both BCBS NC internal appeals and Smart NC external reviews offer expedited processing for urgent situations where delay poses health risks.

Does step therapy apply if I've failed medications outside North Carolina?
Previous treatment failures from other states should be documented and typically satisfy step therapy requirements. Ensure all records are transferred to your current provider.

What happens if Smart NC overturns the denial?
The decision is binding on BCBS NC, and they must provide coverage within 3 business days of the external review decision.

How much does Haegarda cost with BCBS NC coverage?
Costs vary by plan, but as a specialty tier medication, expect significant copays or coinsurance. Manufacturer copay assistance may help reduce out-of-pocket costs.

Quick Reference Checklist

Before Starting

  • Verify BCBS NC plan type and network status
  • Check Haegarda formulary tier and requirements
  • Establish care with HAE specialist if needed

Documentation to Gather

  • HAE diagnosis confirmation (ICD-10 D84.1)
  • Lab results (low C1-INH and C4 levels)
  • Attack history and frequency documentation
  • Prior medication trials and outcomes
  • Training completion certificate
  • Current BCBS NC PA form

Submission Process

  • Complete all form sections accurately
  • Submit via provider portal or fax
  • Follow up within 5-7 business days
  • Track reference numbers and deadlines

If Denied

  • File internal appeal within 180 days
  • Request peer-to-peer review
  • Consider Smart NC external review
  • Contact patient advocacy resources

Sources & Further Reading


Disclaimer: This guide provides general information about insurance coverage and should not be considered medical or legal advice. Insurance requirements and processes may change. Always verify current requirements with your specific insurance plan and consult with your healthcare provider for medical decisions. For personalized assistance with complex prior authorization challenges, consider consulting with specialized advocacy services.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.